Sheel Biotech Ltd (SHEEL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Sheel Biotech Ltd on NSE and BSE, with an AI summary of each filing.
Sheel Biotech Limited has informed the Exchange about receipt of Award of Work having contract value of Rs. 1.72 Crore from Sher-e-Kashmir University of Agricultural Sciences and Technology of Jammu (SKUAST-Jammu) for blueberry production.
Others (Uncategorized) · 30 Oct 2026, 6:46 pm
Sheel Biotech Secures INR 1.72 Crore Turnkey Agricultural Contract from SKUAST-Jammu Sheel Biotech Limited has secured a turnkey Award of Work valued at INR 1.72 Cr via the GeM portal from SKUAST-Jammu, under the NABARD-RIDF-XXXI funded project for blueberry production in J&K. The scope includes establishing a 2,000 sq. meter naturally ventilated polyhouse alongside allied infrastructure such as micro-irrigation, automated fertigation, trellising, packhouse, and cold storage facilities at Research Farm, Chatha, Jammu. This order directly bolsters the company's operational capabilities and aligns with its strategic expansion in the commercial blueberry segment.
Statement of Investor Complaints under Regulation 13(3) of Securities and Exchange Board of India (LODR), 2015 for the quarter ended 30th Sept, 2026.
Others (Uncategorized) · 14 Oct 2026, 8:47 pm
Sheel Biotech Reports Zero Pending Investor Complaints for Q2 FY27 Sheel Biotech Limited submitted its quarterly investor grievance report under Regulation 13(3) of SEBI (LODR) Regulations, 2015, for the quarter ended 30th Sep'26. As certified by its Registrar and Share Transfer Agent, Skyline Financial Services Pvt Ltd, the company recorded zero investor complaints pending at the beginning of the quarter, received zero complaints, resolved zero, and closed the period with nil pending complaints across all platforms, including SEBI SCORES, SEBI ODR Portal, and stock exchanges.
Sheel Biotech Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q2 FY 2026
Others (Uncategorized) · 13 Oct 2026, 11:23 pm
Sheel Biotech Claims Corporate Governance Exemption for Q2 FY27 Sheel Biotech Limited confirmed the non-applicability of Corporate Governance Report submissions under Regulation 27(2) of SEBI LODR Regulations for the quarter ended 30th Sep'26. The company claimed exemption under Regulation 15(2) due to its listing on the NSE SME Platform, which exempts specified SME-listed entities from standard corporate governance compliance mandates under Regulations 17 to 27. Sheel Biotech stated it will comply with the relevant provisions if they become applicable at a later stage.
Sheel Biotech Limited has informed the Exchange regarding ' Award of Work having contract value of Rs. 4.54 Crore from the Department of Agriculture, Government of Himachal Pradesh, for establishment of Demonstration Blueberry Farm and Blueberry Tissue Culture Laboratory
Others (Uncategorized) · 13 Oct 2026, 6:37 pm
Sheel Biotech Bags Rs 4.54 Crore Himachal Pradesh Government Work Order Sheel Biotech Limited secured a work order valued at Rs 4.54 Crore from the Department of Agriculture, Government of Himachal Pradesh, under the Rashtriya Krishi Vikas Yojana (RKVY) Scheme on 13th Oct'26. The contract entails establishing a Demonstration Blueberry Farm and a Blueberry Tissue Culture Laboratory at the Vegetable Seed Multiplication Farm in Bhatoon, Palampur. This project aligns with the company's strategic growth initiatives in the blueberry segment and strengthens its operational capabilities.
Sheel Biotech Limited has informed the Exchange regarding voting results of Annual General Meeting held on September 24, 2026
Annual General Meeting · 25 Sept 2026, 8:52 pm
Sheel Biotech Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2026
Annual General Meeting · 25 Sept 2026, 8:49 pm
Sheel Biotech Limited has informed the Exchange about General Updates
Others (Uncategorized) · 25 Sept 2026, 8:46 pm
SEBI Issues Advisory Letter to Sheel Biotech for Delayed LODR Disclosure Sheel Biotech Limited received an advisory letter dated 3rd Sep'26 from SEBI regarding non-compliance with Regulation 32(6) of SEBI LODR Regulations. The advisory pertains to a delayed disclosure of the Monitoring Agency report issued by CARE Ratings Limited. The letter is purely advisory, imposing no financial penalties, fines, or operational restrictions on the company. Sheel Biotech noted the matter on 25th Sep'26 and confirmed it will ensure strict future compliance to prevent repeat lapses.
Sheel Biotech Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 24, 2026
Annual General Meeting · 24 Sept 2026, 11:38 pm
Sheel Biotech Limited has informed the Exchange as General Updates regarding the Change in Name of the Statutory Auditor firm of the Company
Others (Uncategorized) · 15 Sept 2026, 8:36 pm
Sheel Biotech Announces Name Change of Statutory Auditor Sheel Biotech Limited disclosed under SEBI LODR Regulation 30 that its statutory auditor, M/s Shyam Sunder Mangla & Co LLP, changed its name to M/s S S Mangla & Co LLP. The change is effective from 18th Dec'25 pursuant to a Fresh Certificate of Incorporation issued by the Central Registration Centre, Ministry of Corporate Affairs, under Rule 20(3) of the LLP Rules, 2009. The company received formal intimation of the change from the auditor on 15th Sep'26.
Sheel Biotech Limited has informed the Exchange regarding the finalisation of Commercial Transactions for Blueberry Project amounting to INR 14.53 Crores.
Others (Uncategorized) · 10 Sept 2026, 11:34 pm
Sheel Biotech Finalises ₹14.53 Crore Commercial Deal for Blueberry Project Sheel Biotech Limited has finalised a commercial transaction valued at ₹14.53 Crores for an infrastructure project involving a growing system for its Blueberry project. The disclosure, announced pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 on 10th Sep'26, marks a key development in the company's berry cultivation infrastructure operations.
Sheel Biotech Limited has informed the Exchange regarding regarding Record Date & Book Closure for the purpose of 35th Annual General Meeting
Annual General Meeting · 09 Sept 2026, 9:34 pm
Sheel Biotech Limited has informed the Exchange regarding ''. Clarification on the monitoring agency report
Others (Uncategorized) · 02 Sept 2026, 11:50 pm
Sheel Biotech Clarifies IPO Fund Utilization for Half-Year Ended Mar'26 Sheel Biotech confirmed zero deviations in its IPO fund utilization for the half-year ended Mar'26. Of the Rs. 3,402.00 Lakhs raised, the company utilized Rs. 3,128.37 Lakhs, allocating Rs. 1,588.00 Lakhs to working capital, Rs. 665.95 Lakhs for blueberry greenhouse capex, and Rs. 472.17 Lakhs for general corporate purposes. The unutilized balance of Rs. 273.63 Lakhs remains deployed in fixed deposits. Statutory auditor certificates validate this deployment, resolving any potential market misinterpretation regarding the company's capital allocation execution.
Revised MAR as required by NSE for the Half FY March-26
Others (Uncategorized) · 02 Sept 2026, 12:36 am
Sheel Biotech Limited has informed the Exchange about Copy of Newspaper Publication Newspaper Advertisement for Notice of 35th Annual General Meeting, Intimation of Record Date/Cut-off Date and E-voting Information.
Annual General Meeting · 01 Sept 2026, 6:37 pm
Sheel Biotech Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026
Annual General Meeting · 01 Sept 2026, 12:21 am
Sheel Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on August 31, 2026.
Outcome · 01 Sept 2026, 12:17 am
Sheel Biotech Defers Dividend; Sets AGM and Record Date Sheel Biotech's Board has deferred the dividend for FY26 to retain funds for profitability and growth. The 35th AGM is scheduled for 24th Sep'26 via VC/OAVM. The record date for e-voting eligibility is 17th Sep'26. The Board approved the annual report for FY26 and recommended the re-appointment of Director Sanjay Chandak. A special resolution for the potential sale of immovable property will also be placed before members at the AGM. The share transfer books will be closed from 18th Sep'26 to 24th Sep'26.
SHEEL BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 31-Aug-2026 to consider Other business.
Intimation · 25 Aug 2026, 10:19 pm
Sheel Biotech Board Meeting Scheduled for Other Business Sheel Biotech Limited has announced a Board of Directors meeting scheduled for 31-Aug-26. The primary agenda item disclosed to the exchange is to consider "Other business," indicating potential strategic or operational discussions without specific details being provided at this time.
SHEEL BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 31-Aug-2026 to consider Other business.
Intimation · 25 Aug 2026, 10:19 pm
Sheel Biotech Schedules Board Meeting for Aug'26 Sheel Biotech Limited has announced a board meeting scheduled for 31-Aug-26. The agenda for the meeting is listed as the consideration of "Other business". No specific details regarding the nature of the business to be discussed have been disclosed at this time.
To consider other business matters as per the agenda attached
Others (Uncategorized) · 20 Aug 2026, 10:20 pm
Sheel Biotech Board Meeting on Aug 31 to Finalize FY26 Results and Dividend Sheel Biotech's Board of Directors will meet on 31 Aug'26 to approve the audited financial statements for the year ended 31 Mar'26. Key agenda items include considering a dividend for FY25-26, finalizing the 35th AGM details, recommending director re-appointments, and approving potential sales of land or immovable property. The board will also discuss related party transactions and managerial remuneration. The record date for dividend entitlement and AGM e-voting will be fixed at this meeting.
Sheel Biotech Limited has informed the Exchange about general updates on securing the development of 5 Centres of Excellence (COE) in J&K, having a contract value of 21.39 crore
Others (Uncategorized) · 28 Jul 2026, 6:00 pm
Sheel Biotech Secures ₹21.39 Crore Precision Farming Project in J&K Sheel Biotech secured a Letter of Allotment from J&K Agro Industries Development Corporation (JKAIDCL) on 28th Jul'26. The contract, valued at ₹21.39 crore, is for the turnkey establishment of five Centre of Excellence (COE) facilities for Precision Farming in Jammu & Kashmir. This development is part of the company's strategic growth initiatives and is expected to strengthen its operational capabilities.
Statement of Investor Complaints as per Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Others (Uncategorized) · 23 Jul 2026, 4:16 pm
Sheel Biotech Reports Nil Investor Complaints for Quarter Ended Jun'26 Sheel Biotech filed its investor complaint report for the quarter ended 30th Jun'26, as required by SEBI LODR regulations. The certificate from Registrar and Share Transfer Agent, Skyline Financial Services, confirmed that there were zero complaints pending at the start of the quarter. Furthermore, no new complaints were received from any source, including SEBI SCORES or stock exchanges, during the period. Consequently, no complaints remained unresolved at the end of the quarter, indicating a clean record for investor grievances.
Sheel Biotech Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__
Others (Uncategorized) · 17 Jul 2026, 8:57 pm
Sheel Biotech Claims Exemption from Corporate Governance Reporting for Q1 FY27 Sheel Biotech (SHEEL) announced it will not submit the Corporate Governance Report for the quarter ending 30 Jun'26. The company claims exemption under Regulation 15(2) of SEBI (LODR) Regulations, 2015. This exemption applies as Sheel Biotech's specified securities are listed on the NSE SME Platform. Therefore, the compliance requirements under Regulations 17 to 27 are not applicable. The company stated it will comply with the provisions if they become applicable in the future.
Sheel Biotech Limited has informed the Exchange regarding ''.
Others (Uncategorized) · 14 Jul 2026, 11:35 pm
Sheel Biotech Pivots to High-Value Blueberry Farming to Drive Future Growth Sheel Biotech is strategically expanding into premium berry farming, leveraging its 35 years of agri-horticulture expertise. This pivot targets the high-growth Indian blueberry market, where demand grows at an 18% CAGR and a significant supply gap exists. The company projects FY26 revenue of ₹110 Cr+ and plans an IPO on NSE Emerge in 2025. It will utilize its existing infrastructure, including tissue culture labs and cold chain capabilities, to establish an end-to-end blueberry business encompassing planting material sales, turnkey farm setups, and managed agri-investment projects.
The Exchange had sought clarification from Sheel Biotech Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Half Yearly figures not submitted by the Company The response of the Company is enclosed.
Others (Uncategorized) · 08 Jul 2026, 4:43 pm
Sheel Biotech Issues Revised FY26 Financials on Exchange Request Sheel Biotech submitted revised audited financials for the year ended 31-Mar-26, following a clarification request from the exchange. FY26 revenue grew 8.3% YoY to Rs. 11,073.51 lakhs, with profit after tax rising 9.3% YoY to Rs. 1,175.64 lakhs. Total assets increased 28.7% YoY to Rs. 14,578.43 lakhs. The resubmission corrects previous omissions, including half-yearly figures, segment details (single "agriculture" segment), and a required note on balancing figures between audited annuals and published year-to-date results.
Sheel Biotech Limited has informed the Exchange regarding Appointment of Mr Satbir Singh as Chief Financial Officer of the company w.e.f. July 03, 2026.
Change in Management · 03 Jul 2026, 9:45 pm
Sheel Biotech Appoints Satbir Singh as Chief Financial Officer Sheel Biotech appointed Mr. Satbir Singh as Chief Financial Officer and Key Managerial Personnel, effective 03rd Jul'26. The appointment was recommended by the Nomination and Remuneration Committee and Audit Committee. Mr. Singh is a Chartered Accountant with over 16 years of experience in finance, accounting, taxation, and compliance. His expertise includes financial planning, reporting, internal controls, and treasury management. The company states he has a proven record of leading finance functions and driving operational excellence.